4Semenov A V, Kogan - ponomarev Mia, Ruda Mia. Soluble P - Se- lection a Marker of Platelet Activation and Vessel Wall Injury : In- crease of Soluble P - selection in plasma of patients with Myoear- dial Infraction Massine Atherosclerosis and Primary pulorouary Hy- pertension [J]. Ter Arkh,2000,72(4) :15 -20. 被引量：1
5Michels M,Van der Ven AJ, Djamiatun K,et al. Imbalance of An- giopoietin - 1 and Angiopoietin - 2 in severe Dengue and Relation- ship with Thromboeytopenia,Eendothelial Activation,and Vascular Stability [J]. Am J Trop Med Hyp,2012,87(5) :943 -946. 被引量：1
6Ferroni P,Martini F,Riondino S,et al. Soluble P- seleetin as a marker of in vivo patelet activation[ J]. Clin Chim Acta,2009,399 (1-2):88-91. 被引量：1
7Ay C,Jungbaner LV, Kaider A,et al. P- seleetin gene haplotypes modulate soluble P - seleetin eoneentrations and contribute to the risk of venous thromboembolism [ J ]. Thromb Haemost, 2008,99 (5) :899 -904. 被引量：1
8Malyszko J, Malyszko JS, Mysliwiec M. Markers of endothelial cell injury and thrombin aetivatahle fibrinolysis inhibitor in nephritic syndrome [J]. Blood Coagul Fibrinolysis,2002,13(7) :615 -621. 被引量：1
10Morel - Kopp MC, Mclean L, Chen Q,et al. The association of de- pression with platelet activation: evidence for a treatment effect [ J]. J Thromb Haemost ,2009,7 (4) :573 - 581. 被引量：1
6Cybulsky MI, Iiyama K, Li H, et al. A major role for VCAM-1, but not ICAM-1 ,in early atherosclerosis. J Clin Invest,2001,107(10) : 1255 - 1262. 被引量：1
8Shulman K, Rosen S, Tognazzi K, el al. Expression of vascular permeability factor (VPF/VEGF) is ahered in many giomerular diseases. J Am Soc Nephrol,1996,7(5) : 661 -666. 被引量：1
9Kang DH, Kanellis J, Hugo C, et al. Role of the microvascular endothelium in progressive renal disease. J Am Sec Nephrol,2002,13 (3) : 806 -816. 被引量：1
10van Dokkum RP, Buikema H. Possible new druggable targets for the treatment of nephrosls: Perhaps we should find them in caveolea? Curr Opin Pharmacol,2009,9 ( 2 ) : 132 - 138. 被引量：1
